An interventional study of FitJoints Multi-modal Intervention in Hip Osteoarthritis and Knee Osteoarthritis, sponsored by McMaster University. Recruiting at 4 sites in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-07-01.
Sponsored by McMaster University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Osteoarthritis, Hip with a site in Canada — 9 open to participants now, 13 under way, none of them phase 3. Osteoarthritis, Hip · Canada.
Among the 49 studies in Osteoarthritis, Hip with a site in Canada, this one is the 14th largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2022, is one of 32 with no phase, reaches primary completion later than 3 of the 12 other live ones, and was the 35th registered.
642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.
Browse Osteoarthritis, Hip studies →9 of the 49 studies in Osteoarthritis, Hip with a site in Canada are open now. Recruiting first, the newest first:
University Health Network, Toronto · Sites in Canada
Ages 40–80
University of British Columbia · Sites in Canada
Ages 50+
University of Alberta · Sites in Canada
Canadian Radiostereometric Analysis Network · Sites in Canada
Ages 21+ · Healthy volunteers
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 5 · Phase 4 2
First in 2004; this study’s year is marked. 2 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 192 is above the median of 90 across 458 interventional studies indexed under Osteoarthritis, Hip.
Median enrollment 96 across the 41 interventional studies, 70 across the 8 observational. Of the 30 that completed or were terminated, 8 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 49 have an industry lead sponsor. The 10 most frequent:
McMaster University is the lead sponsor of 742 studies on the registry; 127 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.
McMaster University has 6 studies filed under Osteoarthritis, Hip — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoarthritis, Hip with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06878417University Health Network, TorontoCannabinoids for Osteoarthritis Pain Effectiveness Trial | 2026-12-31 |
| NCT03372278Zimmer BiometPMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty | 2027-01 |
| NCT05543941Ottawa Hospital Research InstituteEvaluating XPERIENCE™ Advanced Surgical Irrigation | 2027-03-31 |
| NCT06173713Canadian Radiostereometric Analysis NetworkEmphasys Radiostereometric Analysis | 2027-08-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 49 studies in Osteoarthritis, Hip with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Total hip or knee replacement is an important and cost-effective surgical intervention to relieve pain and improve independence and function in patients with osteoarthritis. The number of people waiting for elective surgeries has spiked in the COVID-19 pandemic. Prior to COVID-19, up to 40% of patients receiving joint replacement were frail and this number is rapidly increasing with longer wait-times and deconditioning associated with COVID-19 physical distancing. There is an urgent need to be responsive to the evolving challenges of healthcare. The proposed study is the first multi-site randomized controlled trial (RCT) to examine whether a multimodal frailty reduction intervention before surgery will improve postsurgical outcomes for this population. The COVID-19 adapted hybrid model includes a multimodal frailty intervention that may be implemented either in person or virtually and is aligned with international consensus guidelines on frailty reduction.
To utilize the FitJoints multimodal frailty intervention to build resilience of patients undergoing joint replacement surgery to improve post-operative outcomes. The investigators hypothesize the FitJoints multimodal frailty intervention, with exercise, nutrition and medication optimization, will reduce frailty and pain while improving function and quality of life.
Building upon the success of the FitJoints feasibility study (n=69) in Hamilton, Ontario, in the proposed multi-site RCT (n=192), older adults (≥60 years) undergoing hip or knee joint replacement surgery who are frail will be randomized to either the 3 to 6-months of multimodal intervention or usual care until the date of their surgery at multiple sites (Hamilton Health Sciences \& St Joseph's Healthcare Hamilton, ON; London Health Science Centre, London, ON; Foothills Hospital, Calgary, AB),The FitJoints evidence-based, multimodal intervention includes a hybrid model that can be implemented either in person or virtually:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in the control arm will receive usual care which involves patient education that all participants who are scheduled for hip/knee replacement receive at the arthroplasty centre. This may include recommendations to attend fitness classes or discuss nutrition tips and smoking cessation initiatives with their family doctor or other healthcare provider before surgery.
Other: FitJoints Multi-modal Intervention
Exercise: The study physiotherapist will prescribe an exercise program tailored to the participant's individual ability and preference with functional movements to mimic activities of daily living. Nutritional consultation and protein supplement: The site research assistant will coach participants to improve their nutrition, determine their daily protein target, and provide educational tools on how to achieve their target. Protein supplements will be provided to participants. Vitamin D: Participants will be provided with vitamin D3 (1000 IU) tablets to reduce the risk of falls and to preserve muscle strength and functional ability. They will be instructed to take one tablet daily for the duration of the intervention period. Medication optimization: The study pharmacist will conduct a medication review and provide, if required, recommendations for medication optimization.
Between-group Difference in Physical Performance
Assessed by the Short Physical Performance Battery (SPPB), which consists of the following sub-components: * 4-meter walk test (walking speed): measured in seconds, scored 0 to 4 * Chair rise: the ability to rise from a chair without arms: measured in seconds, scored 0 to 4 * Standing balance test: measured in seconds, scored 0 to 4 Sub-component scores will be aggregated to produce an overall SPPB score, with higher scores indicating lower level of frailty \[range 0-12\].
Time frame: 3-months post-operative
Between-group Difference in Frailty
Assessed by the Fit-Frailty Index. Higher scores indicate greater degree of frailty \[range 0-1\].
Time frame: 3-months post-operative
Between-group Difference in Knee Function/Pain
Patient-reported knee function/pain, assessed by the Oxford Knee Score. Higher scores indicate better knee functionality \[range 0-48\].
Time frame: 3-months post-operative
Between-group Difference in Hip Function/Pain
Patient-reported hip function/pain, assessed by the Oxford Hip Score. Higher scores indicate better hip functionality \[range 0-48\].
Time frame: 3-months post-operative
Between-Group Difference in Instrumental Activities of Daily Living
Ability to carry out instrumental activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform instrumental activities of daily living \[range 0-14\].
Time frame: 3-months post-operative
Between-group Difference in Physical Activities of Daily Living
Ability to carry out physical activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform physical activities of daily living \[range 0-14\].
Time frame: 3-months post-operative
Between-group difference in Sarcopenia
Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls. Higher scores indicate greater level of sarcopenia, with scores equal to or greater than 4 predictive of sarcopenia and poorer outcomes \[range 0-10\].
Time frame: 3-months post-operative
Between-group Difference in Nutrition
Assessed by the Mini Nutritional Assessment (MNA). Higher scores indicate better nutritional status (\<17 malnourished, 17-23.5 at risk of malnutrition, 24-30 normal nutritional status) \[range 0-30\].
Time frame: 3-months post-operative
Between-group Difference in Cognition
Ottawa-3DY-cognitive assessment - recall of day of week, date, year, spell WORLD backwards. Score of 4 indicates normal mental status, \<4 indicates impaired mental status \[range 0-4\].
Time frame: 3-months post-operative
Between-group Difference in Health-Related Quality of Life
Quality of life questionnaire (EQ-5D-5L) which consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension in the EQ-5D-5L has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health).
Time frame: 3-months post-operative
Between-group Difference in Number of Hospitalizations
Number of hospitalizations will be recorded. Higher numbers of hospitalizations indicates higher healthcare utilization.
Time frame: 3-months post-operative
Between-group Difference in Number of Emergency Department Visits
Number of emergency department visits will be recorded. Higher number of emergency department visits indicates higher healthcare utilization.
Time frame: 3-months post-operative
Between-group Difference in Number of Visits to Physicians/Healthcare Professionals
Number of visits to physicians and other healthcare professionals will be recorded. Higher number of visits indicates higher healthcare utilization.
Time frame: 3-months post-operative
Between-group Difference in Number of Post-operative Complications
Any post-op complications (e.g. number of infections, peri-prosthetic fractures, bleeding) will be recorded.
Time frame: 3-months post-operative
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2022 (actual). Primary completion is estimated for Mar 2026, 45 months after the start.
Of 201 non-industry interventional studies with no phase under Osteoarthritis, Hip, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 45 months is above that.
Counting every sponsor, half of 227 studies reached it within 29 months; a quarter within 14 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.